Omar Usmani

Professor Omar Usmani is a Professor of Respiratory Medicine at the National Heart and Lung Institute (NHLI), Imperial College London, and Consultant Physician at the Royal Brompton Hospital. He leads the Clinical Research Group within NHLI's Airway Disease Section and is Co-Director of Imperial's Network of Excellence in Aerosols and Health. His expertise spans inhaled drug delivery, small airways physiology, and tele-monitoring. He holds leadership roles in global societies like ISAM (President-elect) and ERS (former Head of Assembly 5). Key awards include the Thomas T. Mercer Award (2015) and FERS (2019).

Education: MB BS (King's College London), PhD (Imperial College London), CASLAT (Imperial College). His research has secured grants including EU Horizon 2020 (myaircoach) and FDA funding ($2.3M). Teaching roles include leading Imperial's MBBS Phase 1 programme and mentoring PhD/MSc students. Public outreach includes STEM initiatives for underprivileged London schoolchildren and media appearances on BBC's Horizon and Fake Britain.

Research focuses on optimizing inhaled therapies, aerosol science, and small airways dysfunction. Articles highlight innovations in drug delivery, telehealth, and inhaler adherence. He advises pharmaceutical companies and regulatory bodies like the FDA on inhaler design and clinical outcomes.